Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novamind Inc (OP: NVMDF )

N/A UNCHANGED
Last Price Updated: 3:36 PM EDT, Jun 13, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2700
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Exclusive: New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions
Bienstar Wellness Brasil Ltda., a subsidiary of Bienstar Wellness  Corp., has entered into a joint venture agreement  with  Dr. Sun Clinic, a Brazil-based clinic with more than 30 years of experience... 
Via Benzinga
EXCLUSIVE: Bienstar Wellness Starts Treating Patients With Psychedelic Therapy In Brazil, Acquires BRC Saude Mental
Zinger Brief The acquisition of BRC Saude Mental & Terapias Assistidas Ltda. provides Bienstar access to the Brazilian market, the largest in Latin America, with a population of 215 million. Ketamine... 
Via Benzinga

Performance

More News

Read More
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
Via Benzinga
New Acquisition: Novamind To Buy Common Shares Of Numinus Pending Canadian Supreme Court Approval
Via Benzinga
Numinus to Acquire Novamind For $20.74M In Stock
Via Benzinga
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
Via Benzinga
Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress
Via Benzinga
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies
Via Benzinga
Novamind And Numinus Prepare For Acquisition, Both Companies Share Info Circulars To Shareholders
Via Benzinga
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward
Via Benzinga
Novamind To Offer Virtual Mental Health Therapy Sessions
Via Benzinga
Numinus Wellness Strives To Become Psychedelic Research Hub After Acquisition Of Novamind Inc.
Via Benzinga
Core One Labs Begins Trading On OTCQB
Via Benzinga
EXCLUSIVE: Bienstar Wellness Enters Brazilian Psychedelic Market, Will Acquire Ibogaine Co.
Via Benzinga
Novamind To Offer Psychedelic-Assisted Group Therapy
Via Benzinga
Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study
Via Benzinga
Novamind To Host MindMed Phase IIb Trial For LSD Based Drug For Anxiety Treatment
Via Benzinga
Novamind Begins Clinical Trial Of Psilocybin For Depression
Via Benzinga
Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial
Via Benzinga
Novamind Stock Slightly Up On Grants Restricted Share Units
Via Benzinga
Novamind To Conduct Phase II Psilocybin Trial For Major Depressive Disorder
Via Benzinga
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
Via Benzinga
Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results
Via Benzinga
Novamind Posts Record High Revenue Of CA$2.45M, Up 32% QoQ
Via Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.